Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.25%
1,104.10
+2.73
+0.25%
1,101.371,103.631,105.311,091.41
SIXC
Communications
SIXC
Communications
SIXC
-1.50%
604.16
-9.19
-1.50%
613.35613.35613.35601.49
SIXE
Energy
SIXE
Energy
SIXE
-0.09%
1,197.81
-1.02
-0.09%
1,198.831,199.681,199.751,182.41
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,740.41
-15.54
-0.88%
1,755.951,754.061,756.031,734.69
SIXM
Financials
SIXM
Financials
SIXM
-0.64%
634.44
-4.07
-0.64%
638.51637.41637.41633.05
SIXR
Staples
SIXR
Staples
SIXR
-0.31%
840.90
-2.62
-0.31%
843.52843.35846.40837.93
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.38%
215.13
-0.82
-0.38%
215.95215.95216.84215.06
SIXT
Technology
SIXT
Technology
SIXT
+2.86%
3,228.71
+89.80
+2.86%
3,138.913,189.303,230.853,174.76
SIXU
Utilities
SIXU
Utilities
SIXU
+0.16%
935.87
+1.50
+0.16%
934.37934.72938.26927.50
SIXV
Health care
SIXV
Health care
SIXV
-1.37%
1,457.12
-20.31
-1.37%
1,477.431,474.121,474.121,451.80
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.83%
2,399.84
+19.65
+0.83%
2,380.192,389.342,403.042,380.47
AUPH:NASDAQ
Aurinia Pharmaceuticals Inc
$15.98
-0.99%
(-0.16) 1D
$15.77
-1.32% (-0.21)
After hours
Closed: Apr 24, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AUPH...
Open
$16.03
High
$16.34
Low
$15.88
Mkt. cap
2.08B
Avg. vol.
1.09M
Volume
1.28M
P/E ratio
7.72
52-wk high
$16.54
52-wk low
$7.28
EPS
$2.07
Beta
1.51
Shares outstanding
132.97M
No. of employees
128
News stories
From sources across the web
About Aurinia Pharmaceuticals Inc
CEO-
Employees128
Founded2012
HeadquartersEdmonton, Alberta, Canada
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
62.46M
70.01M
73.47M
77.11M
Cost of goods sold
14.32M
14.55M
8.50M
40.55M
Cost of revenue
14.32M
14.55M
8.50M
40.55M
Research and development expenses
-
-
8.11M
-20.86M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
20.34M
26.02M
26.18M
29.26M
Operating expense
24.77M
35.26M
35.22M
-6.37M
Total operating expenses
39.08M
49.81M
43.72M
34.18M
Operating income
23.38M
20.20M
29.74M
42.94M
Other non operating income
-
-
-
-
EBT including unusual items
24.35M
22.16M
31.96M
35.69M
EBT excluding unusual items
25.88M
22.27M
31.96M
35.69M
Income tax expense
1.00M
643.00K
411.00K
-175.10M
Effective tax rate
4.13%
2.90%
1.29%
-490.62%
Other operating expenses
4.43M
9.25M
929.00K
-14.77M
Net income
23.34M
21.51M
31.55M
210.79M
Net profit margin
37.37%
30.73%
42.95%
273.35%
Earnings per share
0.16
0.16
0.23
1.53
Interest and investment income
3.57M
3.19M
3.32M
3.50M
Interest expense
-1.07M
-1.12M
-1.10M
-1.05M
Net interest expenses
2.50M
2.07M
2.22M
2.45M
Depreciation and amortization charges
-
-
-
-
EBITDA
28.24M
25.06M
34.61M
47.80M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more